Endurant Capital Management LP Aldeyra Therapeutics, Inc. Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$6.0 - $9.0 $141,456 - $212,184
-23,576 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$7.14 - $9.85 $307,469 - $424,170
-43,063 Reduced 64.62%
23,576 $213,000
Q4 2018

Feb 14, 2019
SELL
$7.26 - $13.29 $24,400 - $44,667
-3,361 Reduced 4.8%
66,639 $553,000
Q3 2018

Nov 14, 2018
BUY
$6.8 - $14.35 $476,000 - $1 Million
70,000 New
70,000 $966,000

Others Institutions Holding ALDX

# of Institutions
117
Shares Held
36.4M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $274M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email